Transportation conditions for prompt use of Ex Vivo expanded and freshly harvested clinical-grade bone marrow mesenchymal stromal/stem cells for bone regeneration

Tissue Engineering - Part C: Methods

Volumn 20, Issue 3, 2014, Pages 239-251

  Veronesi, Elena ^a   Murgia, Alba ^a   Caselli, Anna ^b   Grisendi, Giulia ^a   Piccinno, Maria Serena ^a   Rasini, Valeria ^a   Giordano, Rosaria ^c   Montemurro, Tiziana ^c   Bourin, Philippe ^d,k   Sensebé, Luc ^e   Rojewski, Markus T ^f   Schrezenmeier, Hubert ^f   Layrolle, Pierre ^g   Ginebra, Maria Pau ^h   Panaitescu, Carmen Bunu ⁱ   Gómez Barrena, Enrique ^j   Catani, Fabio ^a   Paolucci, Paolo ^a   Burns, Jorge S ^a   Dominici, Massimo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d ETABLISSEMENT FRANÇAIS DU SANG   (France)

^e UNIVERSITÉ PAUL SABATIER   (France)

^f UNIVERSITY OF ULM   (Germany)

^g UNIVERSITÉ DE NANTES   (France)

^h UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

ⁱ VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^j UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^k CSA21   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADHESION; BIOLOGICAL MATERIALS; BIOMATERIALS; BIOMINERALIZATION; BONE; CYTOLOGY; SHIPS; STEM CELLS; THREE DIMENSIONAL; TRANSMISSION CONTROL PROTOCOL; TRANSPORTATION;

ADHESION TO PLASTICS; BONE MARROW MESENCHYMAL; CURRENT GOOD MANUFACTURING PRACTICES; ECTOPIC BONE FORMATIONS; HUMAN SERUM ALBUMINS; OSTEOGENIC DIFFERENTIATION; REGENERATIVE MEDICINE; TRI-CALCIUM PHOSPHATES;

SCAFFOLDS (BIOLOGY);

BIOMATERIAL; CALCIUM PHOSPHATE; HYDROXYAPATITE;

ANIMAL EXPERIMENT; ARTICLE; BIOMINERALIZATION; BONE MARROW; BONE REGENERATION; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CELL THERAPY; CELL TRANSPORTATION; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; EX VIVO STUDY; GOOD MANUFACTURING PRACTICE; HUMAN; HUMAN CELL; IMPLANTATION; IN VIVO STUDY; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SCID MOUSE; TRANSPORT MEDIUM;

ANIMALS; BONE MARROW CELLS; BONE REGENERATION; BUFFERS; CALCIUM PHOSPHATES; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SEPARATION; CELL SURVIVAL; CHORISTOMA; DURAPATITE; EXTRACELLULAR MATRIX; HUMANS; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; OSTEOGENESIS; PRESERVATION, BIOLOGICAL; TISSUE SCAFFOLDS; TRANSPORTATION;

EID: 84896859853     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2013.0250     Document Type: Article

References (60)

1. Sensebe, L., Bourin, P., and Tarte, K. Good manufacturing practices production of mesenchymal stem/stromal cells. Hum Gene Ther 22, 19, 2011.
2. Quarto, R., Mastrogiacomo, M., Cancedda, R., Kutepov, S.M., Mukhachev, V., Lavroukov, A., Kon, E., and Marcacci, M. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 344, 385, 2001.
3. Bruder, S.P., Kurth, A.A., Shea, M., Hayes, W.C., Jaiswal, N., and Kadiyala, S. Bone regeneration by implantation of pu-rified, culture-expanded human mesenchymal stem cells. J Orthop Res 16, 155, 1998.
4. Livingston, T.L., Gordon, S., Archambault, M., Kadiyala, S., McIntosh, K., Smith, A., and Peter, S.J. Mesenchymal stemcells combined with biphasic calcium phosphate ceramics promote bone regeneration. J Mater Sci Mater Med 14, 211, 2003.
5. Tilley, S., Bolland, B.J., Partridge, K., New, A.M., Latham, J.M., Dunlop, D.G., and Oreffo, R.O. Taking tissueengineering principles into theater: augmentation of impacted allograft with human bone marrow stromal cells. Regen Med 1, 685, 2006.
6. Dawson, J.I., and Oreffo, R.O. Bridging the regeneration gap: stem cells, biomaterials and clinical translation in bone tissue engineering. Arch Biochem Biophys 473, 124, 2008.
7. Ciapetti, G., Granchi, D., and Baldini, N. The combined use of mesenchymal stromal cells and scaffolds for bone repair. Curr Pharm Des 18, 1796, 2012.
8. Doucet, C., Ernou, I., Zhang, Y., Llense, J.R., Begot, L., Holy, X., and Lataillade, J.J. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205, 228, 2005.
9. Vogel, J.P., Szalay, K., Geiger, F., Kramer, M., Richter, W., and Kasten, P. Platelet-rich plasma improves expansion of human mesenchymal stem cells and retains differentiation capacity and in vivo bone formation in calcium phosphate ceramics. Platelets 17, 462, 2006.
10. Schallmoser, K., Rohde, E., Bartmann, C., Obenauf, A.C., Reinisch, A., and Strunk, D. Platelet-derived growth factors for GMP-compliant propagation of mesenchymal stromal cells. Biomed Mater Eng 19, 271, 2009.
11. Xia, W., Li, H., Wang, Z., Xu, R., Fu, Y., Zhang, X., Ye, X., Huang, Y., Xiang, A.P., and Yu, W. Human platelet lysate supports ex vivo expansion and enhances osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Cell Biol Int 35, 639, 2011.
12. Bernardo, M.E., Cometa, A.M., Pagliara, D., Vinti, L., Rossi, F., Cristantielli, R., Palumbo, G., and Locatelli, F. Ex vivo expansion of mesenchymal stromal cells. Best Pract Res Clin Haematol 24, 73, 2011.
13. Fekete, N., Gadelorge, M., Furst, D., Maurer, C., Dausend, J., Fleury-Cappellesso, S., Mailander, V., Lotfi, R., Ignatius, A., Sensebe, L., Bourin, P., Schrezenmeier, H., and Rojewski, M.T. Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components. Cytotherapy 14, 540, 2012.
14. Cho, H.S., Song, I.H., Park, S.Y., Sung, M.C., Ahn, M.W., and Song, K.E. Individual variation in growth factor concentrations in platelet-rich plasma and its influence on human mesenchymal stem cells. Korean J Lab Med 31, 212, 2011.
15. Pamphilon, D.H., Selogie, E., and Szczepiorkowski, Z.M. Transportation of cellular therapy products: report of a survey by the cellular therapies team of the Biomedical Excellence for Safer Transfusion (BEST) collaborative. Vox Sang 99, 168, 2010.
16. Yoshikawa, T., Nakajima, H., Takakura, Y., and Nonomura, A. Osteogenesis with cryopreserved marrow mesenchymal cells. Tissue Eng 11, 152, 2005.
17. Liu, G., Shu, C., Cui, L., Liu, W., and Cao, Y. Tissueengineered bone formation with cryopreserved human bone marrow mesenchymal stem cells. Cryobiology 56, 209, 2008.
18. Hunt, C.J. Cryopreservation of human stem cells for clinical application: a review. Transfus Med Hemother 38, 107, 2011.
19. Francois, M., Copland, I.B., Yuan, S., Romieu-Mourez, R., Waller, E.K., and Galipeau, J. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-gamma licensing. Cytotherapy 14, 147, 2012.
20. Lane, T.A., Garls, D., Mackintosh, E., Kohli, S., and Cramer, S.C. Liquid storage of marrow stromal cells. Transfusion 49, 1471, 2009.
21. Nikolaev, N.I., Liu, Y., Hussein, H., and Williams, D.J. The sensitivity of human mesenchymal stem cells to vibration and cold storage conditions representative of cold transportation. J R Soc Interface 9, 2503, 2012.
22. Muraki, K., Hirose, M., Kotobuki, N., Kato, Y., Machida, H., Takakura, Y., and Ohgushi, H. Assessment of viability and osteogenic ability of human mesenchymal stem cells after being stored in suspension for clinical transplantation. Tissue Eng 12, 1711, 2006.
23. Fekete, N., Rojewski, M.T., Furst, D., Kreja, L., Ignatius, A., Dausend, J., and Schrezenmeier, H. GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PLoS One 7, e43255, 2012.
24. Schrezenmeier, H., and Seifried, E. Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred? Vox Sang 99, 1, 2010.
25. Dingari, N.C., Horowitz, G.L., Kang, J.W., Dasari, R.R., and Barman, I. Raman spectroscopy provides a powerful diagnostic tool for accurate determination of albumin glycation. PLoS One 7, e32406, 2012.
26. Ross, D.D., Joneckis, C.C., Ordonez, J.V., Sisk, A.M., Wu, R.K., Hamburger, A.W.N.R.E., and Nora, R.E. Estimation of cell survival by flow cytometric quantification of fluorescein diacetate/propidium iodide viable cell number. Cancer Res 49, 3776, 1989.
27. Wiedmann-Al-Ahmad, M., Gutwald, R., Lauer, G., Hubner, U., and Schmelzeisen, R. How to optimize seeding and culturing of human osteoblast-like cells on various biomaterials. Biomaterials 23, 3319, 2002.
28. Puchtler, H., Meloan, S.N., and Terry, M.S. On the history and mechanism of alizarin and alizarin red S stains for calcium. J Histochem Cytochem 17, 110, 1969.
29. Puchtler, H., and Meloan, S.N. Demonstration of phosphates in calcium deposits: a modification of von Kossa's reaction. Histochemistry 56, 177, 1978.
30. Abdallah, B.M., Ditzel, N., and Kassem, M. Assessment of bone formation capacity using in vivo transplantation assays: procedure and tissue analysis. Methods Mol Biol 455, 89, 2008.
31. Dominici, M., Rasini, V., Bussolari, R., Chen, X., Hofmann, T.J., Spano, C., Bernabei, D., Veronesi, E., Bertoni, F., Paolucci, P., Conte, P., and Horwitz, E.M. Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation. Blood 114, 2333, 2009.
32. Rasini, V., Dominici, M., Kluba, T., Siegel, G., Lusenti, G., Northoff, H., Horwitz, E.M., and Schafer, R. Mesenchymal stromal/stem cells markers in the human bone marrow. Cytotherapy 15, 292, 2013.
33. Dennis, J.E., Konstantakos, E.K., Arm, D., and Caplan, A.I. In vivo osteogenesis assay: a rapid method for quantitative analysis. Biomaterials 19, 1323, 1998.
34. Kuznetsov, S.A., Mankani, M.H., and Robey, P.G. In vivo formation of bone and haematopoietic territories by transplanted human bone marrow stromal cells generated in medium with and without osteogenic supplements. J Tissue Eng Regen Med 7, 226, 2013.
35. Cuomo, A.V., Virk, M., Petrigliano, F., Morgan, E.F., and Lieberman, J.R. Mesenchymal stem cell concentration and bone repair: potential pitfalls from bench to bedside. J Bone Joint Surg Am 91, 1073, 2009.
36. Caldwell, J., Palsson, B.O., Locey, B., and Emerson, S.G. Culture perfusion schedules influence the metabolic activity and granulocyte-macrophage colony-stimulating factor production rates of human bone marrow stromal cells. J Cell Physiol 147, 344, 1991.
37. Miao, D., Murant, S., Scutt, N., Genever, P., and Scutt, A. Megakaryocyte-bone marrow stromal cell aggregates demonstrate increased colony formation and alkaline phosphatase expression in vitro. Tissue Eng 10, 807, 2004.
38. Ahmadbeigi, N., Soleimani, M., Babaeijandaghi, F., Mortazavi, Y., Gheisari, Y., Vasei, M., Azadmanesh, K., Rostami, S., Shafiee, A., and Nardi, N.B. The aggregate nature of human mesenchymal stromal cells in native bone marrow. Cytotherapy 14, 917, 2012.
39. Weber, C., Pohl, S., Portner, R., Wallrapp, C., Kassem, M., Geigle, P., and Czermak, P. Cultivation and differentiation of encapsulated hMSC-TERT in a disposable small-scale syringe-like fixed bed reactor. Open Biomed Eng J 1, 64, 2007.
40. Rosova, I., Dao, M., Capoccia, B., Link, D., and Nolta, J.A. Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells 26, 2173, 2008.
41. Jansen, J., Nolan, P.L., Reeves, M.I., Akard, L.P., Thompson, J.M., Dugan, M.J., and Hanks, S.G. Transportation of peripheral blood progenitor cell products: effects of time, temperature and cell concentration. Cytotherapy 11, 79, 2009.
42. Quan, R.F., Tang, Y.H., Huang, Z.M., Yang, D.S., Li, W., Xu, J.W., and Wu, X.C. Difference of adherence, proliferation and osteogenesis of mesenchymal stem cells cultured on different HA/ZrO2 composites. Chin J Traumatol 15, 131, 2012.
43. Bernhardt, A., Lode, A., Peters, F., and Gelinsky, M. Comparative evaluation of different calcium phosphate-based bone graft granules-an in vitro study with osteoblast-like cells. Clin Oral Implants Res 24, 441, 2013.
44. Scaglione, S., Giannoni, P., Bianchini, P., Sandri, M., Marotta, R., Firpo, G., Valbusa, U., Tampieri, A., Diaspro, A., Bianco, P., and Quarto, R. Order versus disorder: in vivo bone formation within osteoconductive scaffolds. Sci Rep 2, 274, 2012.
45. Mankani, M.H., Kuznetsov, S.A., Marshall, G.W., and Robey, P.G. Creation of new bone by the percutaneous injection of human bone marrow stromal cell and HA/TCP suspensions. Tissue Eng Part A 14, 1949, 2008.
46. Ng, A.M., Tan, K.K., Phang, M.Y., Aziyati, O., Tan, G.H., Isa, M.R., Aminuddin, B.S., Naseem, M., Fauziah, O., and Ruszymah, B.H. Differential osteogenic activity of osteoprogenitor cells on HA and TCP/HA scaffold of tissue engineered bone. J Biomed Mater Res A 85, 301, 2008.
47. Burns, J.S., Rasmussen, P.L., Larsen, K.H., Schroder, H.D., and Kassem, M. Parameters in three-dimensional osteospheroids of telomerized human mesenchymal (stromal) stem cells grown on osteoconductive scaffolds that predict in vivo bone-forming potential. Tissue Eng Part A 16, 2331, 2010.
48. Griffon, D.J., Abulencia, J.P., Ragetly, G.R., Fredericks, L.P., and Chaieb, S. A comparative study of seeding techniques and three-dimensional matrices for mesenchymal cell attachment. J Tissue Eng Regen Med 5, 169, 2011.
49. Geesink, R.G. Osteoconductive coatings for total joint arthroplasty. Clin Orthop Relat Res 53, 2002.
50. Impens, S., Chen, Y., Mullens, S., Luyten, F., and Schrooten, J. Controlled cell-seeding methodologies: a first step toward clinically relevant bone tissue engineering strategies. Tissue Eng Part C Methods 16, 1575, 2010.
51. Zoellner, H., Hofler, M., Beckmann, R., Hufnagl, P., Vanyek, E., Bielek, E., Wojta, J., Fabry, A., Lockie, S., and Binder, B.R. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci 109, 2571, 1996.
52. Garcovich, M., Zocco, M.A., and Gasbarrini, A. Clinical use of albumin in hepatology. Blood Transfus 7, 268, 2009.
53. Baltanas, F.C., Weruaga, E., Valero, J., Recio, J.S., and Alonso, J.R. Albumin attenuates DNA damage in primarycultured neurons. Neurosci Lett 450, 23, 2009.
54. Garcia-Gonzalo, F.R., and Izpisua Belmonte, J.C. Albuminassociated lipids regulate human embryonic stem cell selfrenewal. PLoS One 3, e1384, 2008.
55. Xu, C., He, D., Zeng, L., and Luo, S. A study of adsorption behavior of human serum albumin and ovalbumin on hydroxyapatite/chitosan composite. Colloids Surf B Biointerfaces 73, 360, 2009.
56. Benoit, D.S., Tripodi, M.C., Blanchette, J.O., Langer, S.J., Leinwand, L.A., and Anseth, K.S. Integrin-linked kinase production prevents anoikis in human mesenchymal stem cells. J Biomed Mater Res A 81, 259, 2007.
57. Marastoni, S., Ligresti, G., Lorenzon, E., Colombatti, A., and Mongiat, M. Extracellular matrix: a matter of life and death. Connect Tissue Res 49, 203, 2008.
58. Weszl, M., Skaliczki, G., Cselenyak, A., Kiss, L., Major, T., Schandl, K., Bognar, E., Stadler, G., Peterbauer, A., Csonge, L., and Lacza, Z. Freeze-dried human serum albumin improves the adherence and proliferation of mesenchymal stem cells on mineralized human bone allografts. J Orthop Res 30, 489, 2012.
59. Bonewald, L.F., Harris, S.E., Rosser, J., Dallas, M.R., Dallas, S.L., Camacho, N.P., Boyan, B., and Boskey, A. von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Calcif Tissue Int 72, 537, 2003.
60. Di, G., Wang, J., Liu, M., Wu, C.T., Han, Y., and Duan, H. Development and evaluation of a trehalose-contained solution formula to preserve hUC-MSCs at 4 degrees C. J Cell Physiol 227, 879, 2012.